SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 3rd, 2018 • Pulmatrix, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 29, 2018, between Pulmatrix, Inc. a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT PULMATRIX, INC.Common Stock Purchase Warrant • December 3rd, 2018 • Pulmatrix, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ ], 20192 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [ ]3 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pulmatrix, Inc., a Delaware corporation (the “Company”), up to [ ]4 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of a series of warrants issued pursuant to the Securities Purchase Agreement (the “Purchase Agreement”), dated November , 2018, by and between the Company and the Purchasers signatory thereto.
